Biomarin Pharmaceutical Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Novato, CA
BMRN chart
What traders are saying about $BMRN
Latest postsBiomarin Pharmaceutical Inc news
- BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts
Yahoo Finance ·
- BMRN Stock Rises On Up To $490M Alesta Deal, But Analyst Cuts Price Target To $59 — Here’s Why
Stocktwits ·
- BioMarin Pharmaceutical Inc. (BMRN) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- BioMarin Pharmaceutical Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:BMRN) 2026-11-05
Seeking Alpha ·
- JP Morgan maintains BioMarin Pharmaceutical at Overweight, lowers price target to $86 from $87
TradingView ·
- Neion Bio Taps John Maga as Head of Biologics and CMC to Expand Capabilities In Innovative Development
Yahoo Finance ·
- J.P. Morgan Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Cuts Target Price to $86
Moomoo ·
- BioMarin to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Three talks by rare-disease drugmaker BioMarin will be available live online.
Stock Titan ·
- BioMarin Pharmaceutical (BMRN) Stock Dropped, What Is Behind Its Latest Update?
Simply Wall St ·
- BioMarin Pharmaceutical (NasdaqGS:BMRN) Stock Forecast & Analyst Predictions
Simply Wall St ·
- BioMarin Pharmaceutical Inc (BMRN) Q3 2026 Earnings Call Highlights: First $1 Billion Revenue ...
Yahoo Finance ·
Biomarin Pharmaceutical Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.22B | $2.85B | $2.42B | $2.10B |
| Net income | $348.9M | $426.9M | $167.6M | $141.6M |
| Diluted EPS | $1.80 | $2.21 | $0.87 | $0.75 |
| Total assets (year end) | $7.59B | $6.99B | $6.84B | $6.38B |
| Cash and equivalents (year end) | $1.31B | $942.8M | $755.1M | $724.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Biomarin Pharmaceutical Inc
- Ticker
- BMRN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Novato, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1048477
Frequently asked questions
What exchange is Biomarin Pharmaceutical Inc listed on?
Biomarin Pharmaceutical Inc trades on the Nasdaq under the ticker symbol BMRN.
What industry is Biomarin Pharmaceutical Inc in?
Biomarin Pharmaceutical Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Biomarin Pharmaceutical Inc headquartered?
Biomarin Pharmaceutical Inc's business address on file with the SEC is in Novato, CA.
When does Biomarin Pharmaceutical Inc's fiscal year end?
Biomarin Pharmaceutical Inc's fiscal year ends on December 31.
How much revenue did Biomarin Pharmaceutical Inc report?
Biomarin Pharmaceutical Inc reported $3.22B in revenue for calendar year 2025, according to its SEC filings.